MEREXIUM Trademark

Trademark Overview

On Friday, March 14, 2008, a trademark application was filed for MEREXIUM with the United States Patent and Trademark Office. The USPTO has given the MEREXIUM trademark a serial number of 77422171. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 22, 2009. This trademark is owned by AstraZeneca AB. The MEREXIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases
merexium

General Information

Serial Number77422171
Word MarkMEREXIUM
Filing DateFriday, March 14, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, July 22, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases, cardiovascular diseases, respiratory diseases, inflammation and infection, gastrointestinal diseases and central nervous system diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 19, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSodertalje SE-151-85
SE

Trademark Events

Event DateEvent Description
Wednesday, July 22, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, July 22, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 22, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, December 22, 2008INQUIRY TO SUSPENSION E-MAILED
Monday, December 22, 2008SUSPENSION INQUIRY WRITTEN
Tuesday, June 10, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008LETTER OF SUSPENSION E-MAILED
Tuesday, June 10, 2008SUSPENSION LETTER WRITTEN
Tuesday, June 10, 2008EXAMINER'S AMENDMENT ENTERED
Tuesday, June 10, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT E-MAILED
Tuesday, June 10, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, May 15, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 30, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 30, 2008NON-FINAL ACTION E-MAILED
Wednesday, April 30, 2008NON-FINAL ACTION WRITTEN
Monday, April 28, 2008ASSIGNED TO EXAMINER
Wednesday, April 2, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, April 2, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2008ASSIGNED TO LIE
Friday, March 28, 2008PAPER RECEIVED
Wednesday, March 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

merexium diseases gastrointestinal infection central system nervous inflammation respiratory preparations treatment